A study exploring the use of continuous vital sign monitoring in acutely unwell general medical inpatients.

Not Applicable

• Conditions: Impaired respiratory function; Tachycardia; Hypoxia; Bradycardia; Hyperoxaemia; Public Health - Health service research

• Registration Number: ACTRN12623001318673
• Lead Sponsor: Fisher & Paykel Healthcare Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-12-15
• Last Update Posted: 8 January 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

•Patients admitted under a medical team <24 hours
•Anticipated to remain an inpatient in Wellington hospital for >24 hours
•EWS =/> 4 at time of eligibility assessment

Exclusion Criteria

•Age <18
•Planned surgical intervention requiring transfer to an operating theatre within 24 hours
•Cardiac pacemaker
•Primarily receiving end of life care (Goals of Care D)
•HDB/ICU admissions
•Invasive/non-invasive ventilation
•Imminent need for ICU admission (currently planning for ICU admission)
•Meeting MET call criteria at eligibility assessment (EWS =/>10 or any parameter in ‘blue zone’)
•Practical reasons that a chest wall sensing device cannot be applied (MRI scanner, skin disease, dressings, etc.)
•Cognitive impairment or impaired consciousness precluding informed consent and ability to co-operate with application of continuous monitoring devices
•Pregnancy or breastfeeding

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To establish the level of agreement of RR (respiratory rate) measurements between capnography and both a chest-wall device and a noncontact device[Capnography, a novel chest-wall device and a novel noncontact device. 15 minutes of paired measurements across devices obtained at beginning of trial (mean of 15-minute period will be used)];To determine the distribution of total EWS (early warning score) scores[Respiratory rate will be assessed continuously by a chest-wall device and a noncontact device. Heart rate will be assessed continuously using pulse oximetry and a noncontact device. SpO2 will be assessed continuously using pulse oximetry. Continuous data will be entered into the New Zealand Early Warning Score system in addition to nursing observations. 48-hour period of continuous measurements from the time of device placement (the mean of continuous RR over 10-, 30- and 60-minute periods will be used)]